{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:23:19Z","timestamp":1783002199144,"version":"3.54.5"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>Human carbonic anhydrase (CA, EC 4.2.1.1) isoforms IX and XII are validated antitumor\/\nantimetastatic drug and tumor imaging targets with sulfonamide inhibitors and monoclonal antibodies in clinical\ndevelopment. Coumarins act as isoform-selective inhibitors of these isoforms over the cytosolic and mitochondrial\nones.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We report the synthesis and in vitro CA inhibitory evaluation of a large panel of coumarins incorporating\npyrazole-1-carboxamide moieties. Compounds were fully characterized before the assessment of their inhibitory activity.\nA stopped-flow CO2 hydrase assay was performed for the biological test.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>These coumarins did not inhibit the widespread, off-target isoforms CA I and II (KI &gt;50 \u03bcM), but they were\nsub-micromolar CA IX\/XII inhibitors with an interesting selectivity index higher than the reference compound. Selectivity\nbetween \u03b1- and \u03b2-class of CAs was also promising.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These compounds may be used as leads for the rational design and development of non-sulfonamide CA\nIX\/XII effective inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520623666230220162506","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T12:07:56Z","timestamp":1676894876000},"page":"1217-1223","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated\nCarbonic Anhydrase IX and XII"],"prefix":"10.2174","volume":"23","author":[{"given":"Aditi","family":"Redij","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Bharati Vidyapeeth's College of Pharmacy, Navi Mumbai, 400614, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":true,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, &#34;G. d'Annunzio&#34; University of Chieti-Pescara, Chieti, 66100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petreni","sequence":"additional","affiliation":[{"name":"Neurofarba Dept., Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":true,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Neurofarba Dept., Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunmayee P.","family":"Toraskar","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Bharati Vidyapeeth's College of Pharmacy, Navi Mumbai, 400614, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1152\/physrev.00018.2021","volume":"102","author":"Aspatwar A.","year":"2022","unstructured":"Aspatwar A.; Tolvanen M.E.E.; Barker H.; Syrj&#xE4;nen L.; Valanne S.; Purmonen S.; Waheed A.; Sly W.S.; Parkkila S.; Carbonic anhydrases in metazoan model organisms: Molecules, mechanisms, and physiology. Physiol Rev 2022,102(3),1327-1383","journal-title":"Physiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/BCJ20160115","volume":"473","author":"Supuran C.T.","year":"2016","unstructured":"Supuran C.T.; Structure and function of carbonic anhydrases. Biochem J 2016,473(14),2023-2032","journal-title":"Biochem J"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"Supuran C.T.","year":"2021","unstructured":"Supuran C.T.; Emerging role of carbonic anhydrase inhibitors. Clin Sci 2021,135(10),1233-1249","journal-title":"Clin Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/14756366.2015.1059333","volume":"31","author":"Ozensoy Guler O.","year":"2016","unstructured":"Ozensoy Guler O.; Capasso C.; Supuran C.T.; A magnificent enzyme superfamily: Carbonic anhydrases, their purification and characterization. J Enzyme Inhib Med Chem 2016,31(5),689-694","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"Supuran C.T.","year":"2008","unstructured":"Supuran C.T.; Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008,7(2),168-181","journal-title":"Nat Rev Drug Discov"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/138161208783877884","volume":"14","author":"Supuran C.","year":"2008","unstructured":"Supuran C.; Carbonic anhydrases an overview. Curr Pharm Des 2008,14(7),603-614","journal-title":"Curr Pharm Des"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1517\/17425255.2016.1154534","volume":"12","author":"Supuran C.T.","year":"2016","unstructured":"Supuran C.T.; Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2016,12(4),423-431","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1080\/14756366.2022.2121393","volume":"37","author":"Supuran C.T.","year":"2022","unstructured":"Supuran C.T.; Anti-obesity carbonic anhydrase inhibitors: Challenges and opportunities. J Enzyme Inhib Med Chem 2022,37(1),2478-2488","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1164\/rccm.202206-1209LE","volume":"206","author":"Chen R.","year":"2022","unstructured":"Chen R.; Liao H.; Chen X.; Wang C.; Wu H.; Zheng Z.; Lu J.; Lin J.; Huang Z.; Lin J.; Zhong N.; Zhang N.; Carbonic anhydrase inhibitors: A new dawn for the treatment of obstructive sleep apnea. Am J Respir Crit Care Med 2022,206(8),1049-5","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/13543776.2022.2083502","volume":"32","author":"Nerella S.G.","year":"2022","unstructured":"Nerella S.G.; Singh P.; Arifuddin M.; Supuran C.T.; Anticancer carbonic anhydrase inhibitors: A patent and literature update 2018-2022. Expert Opin Ther Pat 2022,32(8),833-847","journal-title":"Expert Opin Ther Pat"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/med.21713","volume":"40","author":"Mishra C.B.","year":"2020","unstructured":"Mishra C.B.; Tiwari M.; Supuran C.T.; Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med Res Rev 2020,40(6),2485-2565","journal-title":"Med Res Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/ja809683v","volume":"131","author":"Maresca A.","year":"2009","unstructured":"Maresca A.; Temperini C.; Vu H.; Pham N.B.; Poulsen S.A.; Scozzafava A.; Quinn R.J.; Supuran C.T.; Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009,131(8),3057-3062","journal-title":"J Am Chem Soc"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/jm901287j","volume":"53","author":"Maresca A.","year":"2010","unstructured":"Maresca A.; Temperini C.; Pochet L.; Masereel B.; Scozzafava A.; Supuran C.T.; Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010,53(1),335-344","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","volume":"37","author":"Eldehna W.M.","year":"2022","unstructured":"Eldehna W.M.; Taghour M.S.; Al-Warhi T.; Nocentini A.; Elbadawi M.M.; Mahdy H.A.; Abdelrahman M.A.; Alotaibi O.J.; Aljaeed N.; Elimam D.M.; Afarinkia K.; Abdel-Aziz H.A.; Supuran C.T.; Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. J Enzyme Inhib Med Chem 2022,37(1),531-541","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2174\/1871520622666220304184525","volume":"22","author":"Mohammed A.","year":"2022","unstructured":"Mohammed A.; Supuran C.T.; Thacker P.S.; Tiwari P.L.; Goud N.S.; Srikanth D.; Angeli A.; Synthesis and biological evaluation of coumarin carboxamides as selective and potent inhibitors of carbonic anhydrases IX and XII. Anticancer Agents Med Chem 2022,22(14),2647-2654","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.3390\/molecules27144610","volume":"27","author":"Gumus A.","year":"2022","unstructured":"Gumus A.; Bozdag M.; Akdemir A.; Angeli A.; Selleri S.; Carta F.; Supuran C.T.; Thiosemicarbazide-substituted coumarins as selective inhibitors of the tumor associated human carbonic anhydrases IX and XII. Molecules 2022,27(14),4610","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/14756366.2022.2041630","volume":"37","author":"Ony\u0131lmaz M.","year":"2022","unstructured":"Ony\u0131lmaz M.; Koca M.; Bonardi A.; Degirmenci M.; Supuran C.T.; Isocoumarins: A new class of selective carbonic anhydrase IX and XII inhibitors. J Enzyme Inhib Med Chem 2022,37(1),743-748","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","volume":"35","author":"Supuran C.T.","year":"2020","unstructured":"Supuran C.T.; Coumarin carbonic anhydrase inhibitors from natural sources. J Enzyme Inhib Med Chem 2020,35(1),1462-1470","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","volume":"36","author":"Nocentini A.","year":"2021","unstructured":"Nocentini A.; Angeli A.; Carta F.; Winum J.Y.; Zalubovskis R.; Carradori S.; Capasso C.; Donald W.A.; Supuran C.T.; Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021,36(1),561-580","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","volume":"27","author":"Supuran C.T.","year":"2018","unstructured":"Supuran C.T.; Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2018,27(12),963-970","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/metabo11040225","volume":"11","author":"Thacker P.S.","year":"2021","unstructured":"Thacker P.S.; Tiwari P.L.; Angeli A.; Srikanth D.; Swain B.; Arifuddin M.; Supuran C.T.; Synthesis and biological evaluation of coumarin-linked 4-anilinomethyl-1,2,3-triazoles as potent inhibitors of carbonic anhydrases IX and XIII involved in tumorigenesis. Metabolites 2021,11(4),225","journal-title":"Metabolites"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejmech.2016.02.009","volume":"112","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Cheng F.X.; Yuan X.L.; Tang W.J.; Shi J.B.; Liao C.Z.; Liu X.H.; Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo. Eur J Med Chem 2016,112,231-251","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128258","volume":"48","author":"Ahmed E.Y.","year":"2021","unstructured":"Ahmed E.Y.; Elserwy W.S.; El-Mansy M.F.; Serry A.M.; Salem A.M.; Abdou A.M.; Abdelrahman B.A.; Elsayed K.H.; Abd Elaziz M.R.; Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives. Bioorg Med Chem Lett 2021,48","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1016\/j.bmcl.2010.08.017","volume":"20","author":"Liu X.H.","year":"2010","unstructured":"Liu X.H.; Liu H.F.; Chen J.; Yang Y.; Song B.A.; Bai L.S.; Liu J.X.; Zhu H.L.; Qi X.B.; Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Bioorg Med Chem Lett 2010,20(19),5705-5708","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201700035","volume":"14","author":"Saeed A.","year":"2017","unstructured":"Saeed A.; Mahesar P.A.; Channar P.A.; Larik F.A.; Abbas Q.; Hassan M.; Raza H.; Seo S.Y.; Hybrid pharmacophoric approach in the design and synthesis of coumarin linked pyrazolinyl as urease inhibitors, kinetic mechanism and molecular docking. Chem Biodivers 2017,14(8)","journal-title":"Chem Biodivers"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"27627","DOI":"10.1039\/D1RA03970A","volume":"11","author":"Patel M.","year":"2021","unstructured":"Patel M.; Pandey N.; Timaniya J.; Parikh P.; Chauhan A.; Jain N.; Patel K.; Coumarin-carbazole based functionalized pyrazolines: Synthesis, characterization, anticancer investigation and molecular docking. RSC Advances 2021,11(44),27627-27644","journal-title":"RSC Advances"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1016\/j.ejmech.2011.07.017","volume":"46","author":"Secci D.","year":"2011","unstructured":"Secci D.; Carradori S.; Bolasco A.; Chimenti P.; Y&#xE1;&#xF1;ez M.; Ortuso F.; Alcaro S.; Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur J Med Chem 2011,46(10),4846-4852","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","volume":"87","author":"Kurt B.Z.","year":"2019","unstructured":"Kurt B.Z.; Dag A.; Do&#x11F;an B.; Durdagi S.; Angeli A.; Nocentini A.; Supuran C.T.; Sonmez F.; Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorg Chem 2019,87,838-850","journal-title":"Bioorg Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejmech.2014.11.027","volume":"90","author":"Amin K.M.","year":"2015","unstructured":"Amin K.M.; Abou-Seri S.M.; Awadallah F.M.; Eissa A.A.M.; Hassan G.S.; Abdulla M.M.; Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. Eur J Med Chem 2015,90,221-231","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","volume":"246","author":"Khalifah R.G.","year":"1971","unstructured":"Khalifah R.G.; The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971,246(8),2561-2573","journal-title":"J Biol Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/chem.201503748","volume":"22","author":"Langella E.","year":"2016","unstructured":"Langella E.; D\u2019Ambrosio K.; D\u2019Ascenzio M.; Carradori S.; Monti S.M.; Supuran C.T.; De Simone G.; A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases. Chemistry 2016,22(1),97-100","journal-title":"Chemistry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1080\/14756366.2022.2091557","volume":"37","author":"Liguori F.","year":"2022","unstructured":"Liguori F.; Carradori S.; Ronca R.; Rezzola S.; Filiberti S.; Carta F.; Turati M.; Supuran C.T.; Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: An insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J Enzyme Inhib Med Chem 2022,37(1),1857-1869","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14756366.2016.1214951","volume":"31","author":"Mollica A.","year":"2016","unstructured":"Mollica A.; Locatelli M.; Macedonio G.; Carradori S.; Sobolev A.P.; De Salvador R.F.; Monti S.M.; Buonanno M.; Zengin G.; Angeli A.; Supuran C.T.; Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars. J Enzyme Inhib Med Chem 2016,31(S4),1-6","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/14756366.2021.2012174","volume":"37","author":"Giovannuzzi S.","year":"2022","unstructured":"Giovannuzzi S.; Hewitt C.S.; Nocentini A.; Capasso C.; Flaherty D.P.; Supuran C.T.; Coumarins effectively inhibit bacterial &#x3B1;-carbonic anhydrases. J Enzyme Inhib Med Chem 2022,37(1),333-338","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666230220162506","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213833\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520623666230220162506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:32:16Z","timestamp":1691335936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213833\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520623666230220162506","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}